Search Within

Kim Kramer

Formats
  1. Journal Article (128)
  2. Meeting Abstract (100)
  3. Conference Paper (3)
  4. Book Section (2)
  5. Editorial (1)
  6. Guidelines (1)
  7. Research Letter (1)
Groups
  1. Neuro-Oncology Service (236)
  2. Pediatrics, Department of (236)
  3. Neuroblastoma Service (176)
  4. GSK Faculty (173)
  5. Center for Molecular Imaging and Biotechnology (CMIB) (170)
  6. Tow Center for Developmental Oncology (TCDO) (170)

More Groups

People
  1. Nai-Kong Cheung (165)
  2. Brian Kushner (132)
  3. Shakeel Modak (104)
  4. Suzanne Wolden (61)
  5. Neeta Pandit-Taskar (51)
  6. Steven Larson (46)

More People

Years
  1. 2025 (1)
  2. 2024 (9)
  3. 2023 (11)
  4. 2022 (10)
  5. 2021 (9)
  6. 2020 (10)

More Years

Publications
  1. Neuro-Oncology (43)
  2. Pediatric Blood and Cancer (43)
  3. Journal of Clinical Oncology (34)
  4. Cancer (11)
  5. International Journal of Radiation Oncology, Biology, Physics (9)
  6. Medical and Pediatric Oncology (8)

More Publications

Publishers
  1. Oxford University Press (44)
  2. Wiley Periodicals, Inc (43)
  3. American Society of Clinical Oncology (35)
  4. Elsevier Inc. (17)
  5. Springer (15)
  6. American Association for Cancer Research (14)

More Publishers

Results (236)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Two-compartment model of radioimmunotherapy delivered through cerebrospinal fluid
    Journal Article

    He, P.; Kramer, K.; Smith-Jones, P.; Zanzonico, P.; Humm, J.; Larson, S. M.; Cheung, N. K. V.
    European Journal of Nuclear Medicine and Molecular Imaging (2011)

    Fulltext@MSK | Save
  • Two-compartment pharmacokinetics model of radioimmunotherapy with I-131-3F8 directly administered into the cerebrospinal fluid
    Meeting Abstract

    He, P.; Kramer, K.; Smith-Jones, P.; Zanzonico, P.; Humm, J.; Larson, S. M.; Cheung, N. K. V.
    Cancer Research (2010)

    Fulltext@MSK | Save
  • Safety and complication rate associated with ommaya reservoirs in patients receiving radioimmunotherapy (RIT) for central nervous system (CNS) malignancies
    Meeting Abstract

    Smith, M.; Kramer, K.; Souweidane, M. M.
    Neuro-Oncology (2010)

    Fulltext@MSK | Save
  • MRI of typical and atypical focal nodular hyperplasia in treated pediatric oncologic patients
    Meeting Abstract

    Shaylor, S.; Do, R.; Abramson, S.; Price, A.; Wexler, L.; Kramer, K.; Shia, J.; Schwartz, L.
    American Journal of Roentgenology (2010)

    Fulltext@MSK | Save
  • Arsenic trioxide as radiosensitizer for 131i-mibg therapy: Results of a pilot phase II study
    Meeting Abstract

    Modak, S.; Pandit-Taskar, N.; Carrasquillo, J.; Kramer, K.; Kushner, B. H.; Zanzonico, P.; Smith-Jones, P.; Larson, S.; Cheung, N. K. V.
    Pediatric Blood and Cancer (2010)

    Fulltext@MSK | Save
  • Combined radioimmunotherapy and anti-angiogenic therapy for resistant neuroblastoma
    Meeting Abstract

    Modak, S.; Kushner, B. H.; Kramer, K.; Pandit-Taskar, N.; Carrasquillo, J.; Zanzonico, P.; Smith-Jones, P.; Larson, S.; Cheung, N. K. V.
    Pediatric Blood and Cancer (2010)

    Fulltext@MSK | Save
  • Radioimmunotherapy for high-risk and recurrent central nervous system (CNS) cancers: Results of a phase II study with intra-ommaya I-131-3f8
    Meeting Abstract

    Kramer, K.; Smith-Jones, P. M.; Humm, J. L.; Zanzonico, P. B.; Pandit-Taskar, N.; Carrasquillo, J. A.; Modak, S.; Tickoo, S.; Gerald, W. L.; Dunkel, I. J.; more...
    Neuro-Oncology (2010)

    Fulltext@MSK | Save
  • Treatment strategies for recurrent medulloblastoma - Report of a single institution experience
    Meeting Abstract

    Gilheeney, S. W.; McLaren, S.; Dreyfuss, H.; Becher, O. J.; Khakoo, Y.; Kramer, K.; Lyden, D. C.; Souweidane, M.; Wolden, S.; Dunkel, I. J.
    Neuro-Oncology (2010)

    Fulltext@MSK | Save
  • A trial of intra-ommaya (IO) radioimmunotherapy (Rit), reduced-dose external beam craniospinal radiotherapy (Rt) with intensity-modulated radiotherapy (IMRt) boost, and chemotherapy for patients with standard-risk medulloblastoma
    Meeting Abstract

    Dunkel, I. J.; Wolden, S. L.; Souweidane, M. M.; Sklar, C. A.; Khakoo, Y.; Larson, S. M.; Becher, O. J.; Gershon, T. R.; Gilheeney, S. W.; Lyden, D. C.; more...
    Neuro-Oncology (2010)

    Fulltext@MSK | Save
  • Differential impact of high-dose cyclophosphamide, topotecan, and vincristine in clinical subsets of patients with chemoresistant neuroblastoma
    Journal Article

    Kushner, B. H.; Kramer, K.; Modak, S.; Qin, L. X.; Cheung, N. K. V.
    Cancer (2010)

    Fulltext@MSK | Save